Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 47: 1424-1429, 2001;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (15)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schulze, A.
Right arrow Articles by Mayatepek, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schulze, A.
Right arrow Articles by Mayatepek, E.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Proteomics and Protein Markers
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2001;47:1424-1429.)
© 2001 American Association for Clinical Chemistry, Inc.

Articles

Spectrophotometric Microassay for {delta}-Aminolevulinate Dehydratase in Dried-Blood Spots as Confirmation for Hereditary Tyrosinemia Type I

Andreas Schulze1a, David Frommhold1, Georg F. Hoffmann1 and Ertan Mayatepek1

1 Division of Metabolic and Endocrine Diseases, University Children’s Hospital, Im Neuenheimer Feld 150, 69120 Heidelberg, Germany.

aAuthor for correspondence. Fax 49-6221-563714; e-mail andreas_schulze{at}med.uni-heidelberg.de.

Background: Hereditary tyrosinemia type I (HT) fulfills the criteria for inclusion in neonatal screening programs, but measurement of tyrosine lacks clinical specificity and quantitative assay of succinylacetone is laborious. We developed a semiquantitative assay based on inhibition of {delta}-aminolevulinate dehydratase (ALA-D) by succinylacetone.

Methods: Preincubation of 3-mm discs from dried-blood spots and reaction of the enzyme with {delta}-aminolevulinic acid as substrate were performed in microtiter plates. After separation of the supernatant and 10 min of color reaction with modified Ehrlich reagent, the formation of porphobilinogen was measured at 550 nm in a plate reader.

Results: The detection limit for succinylacetone was 0.3 µmol/L; imprecision (CV) was <5.5% within-run and 10–16% between-run. Storage of blood spots at ambient temperature for several days led to a significant decrease of ALA-D activity. Enzyme activity was lost in filter cards at 45 °C, but remained stable at 2–37 °C. Enzyme activity was decreased in EDTA blood. The absorbance at 550 nm was 0.221 (± 0.073) in healthy neonates and 0.043–0.100 in 11 patients with HT. All neonates with increased tyrosine (above the 99.5th centile) in neonatal screening (97 of 47 000) had normal results by the new assay.

Conclusions: The spectrophotometric microassay for ALA-D is a simple and sensitive test for HT. This represents a basis for further examination of its general reliability as a confirmatory test if tyrosine is found to be increased.




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
K. A. Pass and M. Morrissey
Enhancing Newborn Screening for Tyrosinemia Type I
Clin. Chem., April 1, 2008; 54(4): 627 - 629.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
C. Turgeon, M. J. Magera, P. Allard, S. Tortorelli, D. Gavrilov, D. Oglesbee, K. Raymond, P. Rinaldo, and D. Matern
Combined Newborn Screening for Succinylacetone, Amino Acids, and Acylcarnitines in Dried Blood Spots
Clin. Chem., April 1, 2008; 54(4): 657 - 664.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
J. Sander, N. Janzen, M. Peter, S. Sander, U. Steuerwald, U. Holtkamp, B. Schwahn, E. Mayatepek, F. K. Trefz, and A. M. Das
Newborn Screening for Hepatorenal Tyrosinemia: Tandem Mass Spectrometric Quantification of Succinylacetone
Clin. Chem., March 1, 2006; 52(3): 482 - 487.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
C. E.L. Lim, K. I. Matthaei, A. C. Blackburn, R. P. Davis, J. E. Dahlstrom, M. E. Koina, M.W. Anders, and P. G. Board
Mice Deficient in Glutathione Transferase Zeta/Maleylacetoacetate Isomerase Exhibit a Range of Pathological Changes and Elevated Expression of Alpha, Mu, and Pi Class Glutathione Transferases
Am. J. Pathol., August 1, 2004; 165(2): 679 - 693.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
D. H. Chace, T. A. Kalas, and E. W. Naylor
Use of Tandem Mass Spectrometry for Multianalyte Screening of Dried Blood Specimens from Newborns
Clin. Chem., November 1, 2003; 49(11): 1797 - 1817.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
H. B. M. Lantum, J. Cornejo, R. H. Pierce, and M. W. Anders
Perturbation of Maleylacetoacetic Acid Metabolism in Rats with Dichloroacetic Acid-Induced Glutathione Transferase Zeta Deficiency
Toxicol. Sci., July 1, 2003; 74(1): 192 - 202.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
B. Wilcken, V. Wiley, J. Hammond, and K. Carpenter
Screening Newborns for Inborn Errors of Metabolism by Tandem Mass Spectrometry
N. Engl. J. Med., June 5, 2003; 348(23): 2304 - 2312.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
A. Schulze, M. Lindner, D. Kohlmuller, K. Olgemoller, E. Mayatepek, and G. F. Hoffmann
Expanded Newborn Screening for Inborn Errors of Metabolism by Electrospray Ionization-Tandem Mass Spectrometry: Results, Outcome, and Implications
Pediatrics, June 1, 2003; 111(6): 1399 - 1406.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Association for Clinical Chemistry.